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Background: White matter changes measured using diffusion tensor imaging have been reported in
Alzheimer's disease and amnestic mild cognitive impairment, but changes in earlier pre-mild cognitive
impairment stages have not been fully investigated.
Methods: In a cross-sectional analysis, older adults withmild cognitive impairment (n=28), older adults with
cognitive complaints but without psychometric impairment (n=29) and healthy controls (n=35) were
compared. Measures included whole-brain diffusion tensor imaging, T1-weighted structural magnetic
resonance imaging, and neuropsychological assessment. Diffusion images were analyzed using Tract-Based
Spatial Statistics. Voxel-wise fractional anisotropy and mean, axial, and radial diffusivities were assessed and
compared between groups. Signiﬁcant tract clusters were extracted in order to perform further region of
interest comparisons. Brain volume was estimated using FreeSurfer based on T1 structural images.
Results: Themild cognitive impairment group showed lower fractional anisotropy and higher radial diffusivity
than controls in bilateral parahippocampal white matter. When comparing extracted diffusivity measure-
ments from bilateral parahippocampal white matter clusters, the cognitive complaint group had values that
were intermediate to the mild cognitive impairment and healthy control groups. Group difference in diffusion
tensor imaging measures remained signiﬁcant after controlling for hippocampal atrophy. Across the entire
sample, diffusion tensor imaging indices in parahippocampal white matter were correlated with memory
function.
Conclusions: These ﬁndings are consistent with previous results showing changes in parahippocampal white
matter in Alzheimer's disease and mild cognitive impairment compared to controls. The intermediate pattern
found in the cognitive complaint group suggests the potential of diffusion tensor imaging to contribute to
earlier detection of neurodegenerative changes during prodromal stages. This article is part of a Special Issue
entitled: Imaging Brain Aging and Neurodegenerative disease.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
There has been an exponential growth in the number of published
studies characterizing Alzheimer's disease (AD) and its complex
genetic and environmental determinants. In particular, progress in
understanding basic disease mechanisms has lead to new therapeutic
strategies currently undergoing clinical trials. To date results have: Imaging Brain Aging and
and Imaging Sciences, Indiana
E124, Indianapolis, IN 46202,
l rights reserved.been disappointing but there is a widespread perception that
interventions need to be initiated earlier in the course of disease,
prior to the onset of signiﬁcant neurodegeneration. Therefore, a major
focus of much recent research has been on methods that have
potential to yield earlier detection and clinical diagnosis, ideally in the
presymptomatic or early prodromal stages of AD. Amnestic mild
cognitive impairment (MCI) has been widely studied as a prodromal
form of dementia, conferring a 10–15% annual risk of converting to
probable AD [1]. Although neuroimaging has been found to have a
major role in the investigation of MCI and AD, few imaging studies
have examined stages of prodromal AD earlier than MCI (pre-MCI).
We previously described MCI-like gray matter changes on structural
MRI in euthymic older adults, who, despite having marked cognitive
complaints (CC), performed within normal limits relative to peers of
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based morphometry (VBM) ﬁndings, it was suggested that older
adults with cognitive complaints, even when unaccompanied by
deﬁcits on formal testing, may be experiencing underlying neurode-
generative changes [2]. This ﬁnding has been conﬁrmed and extended
by other recent structural and spectroscopic MRI observations in a
pre-MCI sample [3].
Thus far, conventional structural MRI has been mainly used to
demonstrate AD progression related changes in gray matter of the
brain [2–4]. This might be because white matter (WM) changes are
occurring at a microscopic level, but have not accumulated enough to
become obvious macroscopically, resulting in normally appearing
WM on structural MRI [3,5]. Unlike the T1-weighted structural MRI,
diffusion tensor imaging (DTI) is a quantitative MRI technique that
provides in vivo information about the three-dimensional diffusion of
water molecules within the tissue [6]. Speciﬁcally, fractional anisot-
ropy (FA) is a measure of anisotropic water diffusion, and reﬂects the
degree of directionality of cellular structures within theWM ﬁbers [7].
Loss of anisotropic diffusion could be related to abnormalities within
the cellular microstructure. Mean diffusivity (MD) is a directionally
averaged measure of the apparent diffusion coefﬁcient and may help
to better elucidate how WM integrity is changing [6]. Recent animal
models suggested that the diffusivity measure can be further
subdivided into axial and radial components, which could provide
information on axonal and myelin pathology selectively [8]. There-
fore, recent DTI studies have also employed the axial diffusivity (DA)
and radial diffusivity (DR), which quantify the magnitude of water
diffusion parallel and perpendicular to the principal orientation of
WM [9–15]. These may relate more closely to underlying pathology,
because decreases in DA have correlated with axonal loss in some
studies, whereas increases in DR are more characteristic of demye-
lination [16]. More importantly, it has been suggested that exploration
of the full tensor behavior would be advantageous in studying
neurodegeneration rather than assuming that a single metric (such as
FA) is sufﬁciently sensitive to different pathological states [14].
DTI has been used to assess WM changes not detectable with
conventional structural MRI in MCI and AD [9,13,14,16–19], as well as
normal aging [10–12,20,21]. However, ﬁndings of DTI in prodromal
AD have been inconclusive [16]. There are extremely limited DTI
studies in pre-MCI stages [22] andWM alterations in CC patients have
not been investigated. In this study, we examined microstructural
properties of WM underpinnings of memory complaints in older
adults with normal memory test performance compared to in-
dividuals with MCI and healthy controls (HCs). An additional
noteworthy feature of this study relative to prior research is the use
of tract based spatial statistics (TBSS) [23], an automated voxel-wise
analysis method to improve detection and localization ofWM changes
across individuals and groups. We hypothesized that the CC group
would show intermediate changes in WM relative to the MCI and
control groups, especially within episodic memory circuitry, given its
role as the earliest symptom of AD. We also hypothesized that
subjective and objective measures of memory would be directly
related to WM integrity.
2. Material and methods
2.1. Study Participants
Participants were 92 older adults enrolled in the Dartmouth
Memory and Aging Study. The sample included 29 euthymic
individuals with signiﬁcant cognitive complaints despite cognitive
test performance within the normal range (CC group), 28 patients
with amnestic MCI (MCI group), and 35 healthy controls (HC group)
without signiﬁcant cognitive complaints or psychometric deﬁcits.
Further details regarding participant recruitment, selection criteria,
and characterization are available in Saykin et al. (2006) [2].Participants provided written informed consent according to
procedures approved by the Institutional Committee for the Protec-
tion of Human Subjects. Inclusion criteria were at least 60 years of age,
right handed, ﬂuent in English, and at least 12 years of formal
education. Participants were required to have an informant who knew
them well and could answer questions about their cognition and
general health. Exclusion criteria included any medical, psychiatric, or
neurologic condition (other than MCI) that could signiﬁcantly affect
brain structure or cognition, history of head trauma with loss of
consciousness lasting more than 5 min, history of substance depen-
dence, and factors contraindicating MRI. Non-amnestic forms of MCI
[24] were excluded, although amnestic MCI with involvement of
multiple domains was permitted.
2.2. Neuropsychological assessment
Participants underwent a detailed neuropsychological evaluation,
including measures of memory, attention, executive function, lan-
guage, spatial ability, general intellectual ability, and psychomotor
speed as well as standard dementia screens. Tests included Mini-
Mental State Examination (MMSE) [25], Mattis Dementia Rating
Scale-2 [26], California Verbal Learning Test (CVLT-II) [27], Boston
Naming Test [28], selected subtests from the Delis–Kaplan Executive
Function System (D-KEFS) [29], Wisconsin Card Sorting Test [30],
selected subtests from the Wechsler Adult Intelligence Scale III and
Wechsler Memory Scale III [31]. For the CVLT-II test, participants
were randomly administered either the standard or alternate test
forms to reduce practice effects engendered by multiple adminis-
trations of the same items. Form equivalency has been demonstrated
by previous research and test forms were balanced across partici-
pant groups and balanced across participants within each group
(χ2=1.262, pN .05).
Multiple inventories were employed to assess subjective cognitive
ability, including the Memory Self-Rating Questionnaire, self and
informant versions of the Neurobehavioral Function and Activities of
Daily Living Rating Scale [32], self and informant versions of the
Informant Questionnaire on Cognitive Decline in the Elderly [33], the
four cognitive items from the Geriatric Depression Scale (GDS) [34],
and 23 items from the Memory Assessment Questionnaire [35]. A
Cognitive Complaint Index was calculated as the percentage of all
items endorsed [2].
Group classiﬁcations (HC, CC, MCI) were based on results of the
neuropsychological assessment, self and informant report indices, and
the geriatric and neurologic evaluations. A multidisciplinary clinical
consensus panel reviewed each case according to speciﬁc criteria
which are available elsewhere [2].
2.3. MRI acquisition
The MRI was acquired on a GE Signa 1.5 T Horizon LX magnet with
echo speed gradients using a standard head RF coil. DTI acquisition
was conducted using a two-dimensional spin-echo sequence with an
echo planar readout (SE-EPI-DTI) and a pair of diffusion weighting
(DW) gradients positioned symmetrically around the 180° pulse [7].
DTI parameters: TR/TE=8000/78 ms, 36 axial slices with 3 mm
thickness, 128×128 image matrix, 24 cm×24 cm ﬁeld of view. The
amplitude of the total diffusion gradient was 20 mT/m and was
applied in 12 non-collinear directions uniformly distributed in three-
dimensional space (minimum energy scheme) [36]. The effective
diffusion weighting was b=800 s/mm2. Two image-volumes with no
diffusion weighting (b=0 s/mm2) were also acquired at the
beginning of each DTI scan. Acquisition of all b=800 s/mm2 and
b=0 s/mm2 images was repeated 4 times. The duration of the DTI
scan was about 7 min. In addition, a T1-weighted three-dimensional
spoiled gradient echo (SPGR) acquisition with TR/TE=25/3 ms, ﬂip
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resolution of 0.9375 mm was performed for anatomic reference.
2.4. Imaging analysis
The DTI data were analyzed using the FSL package (FMRIB Center,
Oxford, United Kingdom). Preprocessing included correction for
motion and eddy current effects in DTI images. Subsequently, FMRIB's
Diffusion Toolbox [37] was used to ﬁt the tensor model and to
compute the FA, MD, DA and DR maps. After that, TBSS analysis was
utilized [23]. TBSS addresses many concerns regarding previous
methods of whole brain voxel-by-voxel analyses of diffusion-
weighted data, including reliable registration of subjects to a common
space, choice of smoothing kernel, and partial volume effects [9–
14,16,17]. All individual FA maps were nonlinearly registered to the
template and then afﬁne-transformed into standard Montreal
Neurological Institute (MNI) space. A mean WM skeleton was
generated based on the mean FA image of all subjects. Each subject's
aligned FA image was projected onto the mean FA skeleton, and
voxel-wise group comparisons of FA values were conducted along the
skeleton. Voxel-wise analysis of MD, DA and DR maps was conducted
in the same manner using the same FA skeleton.
To determine degree of brain atrophy, each participant's cortical
and subcortical tissue volume and intracranial volume (ICV) were
estimated using automatic parcellation as implemented in the
FreeSurfer software package [38] based on T1-weighted (SPGR)
anatomical images as described in our previous publications [4,39].
2.5. Statistical analysis
All skeletonized DTI maps were included in voxel-wise group
statistical analyses using a generalized linear model approach with
age and gender as covariates. Inference on these statistics was carried
out using the “randomize” program within FSL, which performs
permutation testing (5000 permutations) that does not rely on a
Gaussian distribution [40]. With this approach, voxel-wise differences
among groups applying two-sample t tests were assessed. Correction
for multiple comparisons was achieved through a combination of
individual voxel probability and cluster size thresholding usingMonte
Carlo simulation for Type I error control (αb0.05) [41–43]. As
estimated by the simulation, only clusters with an individual voxel
threshold of pb0.01, yielding a brain-wise probability at pb0.05 of
ﬁnding such a cluster under the null hypothesis, were considered
signiﬁcant at pb0.01 (corrected) [42,43].
For exploratory ROI analyses, mean DTI indices values for each
subject were extracted from clusters showing signiﬁcant between-
group differences in FA. MANOVA (multivariate analysis of variance)Table 1
Sample characteristics.
HC
(n=35)
CC
(n=29)
MCI
(n=28)
F/χ2
Age (yrs) 71.6 (5.2) 73.4 (6.3) 74.3 (5.8) 1.639
Education (yrs) 16.7 (2.7) 16.6 (3.0) 16.6 (3.0) 0.002
Gender (M/F) 10:25 11:18 15:13 4.107
MMSE 28.9 (1.2) 28.8 (1.1) 27.0 (1.9) 15.840
DRStot 141.4 (1.8) 141.1 (2.3) 137.8 (3.1) 20.643
CVLT-IItot 50.1 (7.8) 47.7 (9.6) 34.7 (8.2) 28.191
CVLT-II_SD 11.5 (2.4) 10.7 (3.3) 6.1 (2.8) 31.663
CVLT-II_LD 12.3 (2.5) 10.9 (3.3) 6.6 (3.1) 28.409
WMS-III_LM 52.2 (6.4) 46.0 (8.1) 37.4 (9.8) 22.974
WMS-III_LMD 34.1 (4.7) 28.9 (6.2) 22.8 (7.4) 23.316
Note: Demographic and cognitive characteristics include mean (standard deviation) for
impairment; NS=not signiﬁcant; MMSE=Mini-Mental State Examination (max 30); DRS
Learning Test-II total learning raw scores (max 80); CVLT-II_SD=California Verbal Learning
long delay raw scores (max. 16);WMS-III_LM=Wechsler Memory Scale-III, logical memor
logical memory delay recall raw scores (max. 50).was performed using the Statistical Package for Social Sciences (SPSS,
v. 18.0) to assess differences in DTI indices between groups. A series of
covariance analyses was used to assess the relationships between
neuropsychological performance and mean DTI indices. For demo-
graphic and cognitive variables comparison, ANOVAs were employed
with Tukey's post-hoc or χ2 tests for categorical variables. Partial
correlations controlling for participants' age and gender were
performed to investigate relationships between cognitive indices,
and areas across the multiple tensor parameters showing group
differences. To investigate if atrophy inﬂuenced DTI results, all
analyses were repeated adjusting for tissue volumes.3. Results
3.1. Subject characteristics
The three groups of participants did not differ signiﬁcantly with
respect to age and education (Table 1), although the mean age was
slightly higher for the CC and MCI groups than for the HC participants.
Male-to-female ratio among the three groups was not signiﬁcantly
different by χ2 test but also was not perfectly balanced. Thus, Age and
gender were entered as covariates in all statistical analyses of DTI
[10,12,43]. Assessment of cognitive performance was based on age,
education, and gender-adjusted scores, as applicable [2]. As expected,
MCI patients had signiﬁcantly lower mean MMSE, DRS-2 total scores
and CVLT-II scores than the CC and HC groups (see Table 1). The CC
and HC groups did not differ from each other in terms of performance
on the MMSE, DRS-2 and CVLT-II scores. Although signiﬁcant
differences among all three groups were found on the WMS-III
Logical Memory immediate and delay scores (MCIbCCbHC), memory
performance of CC group is still considered within the normal range
[2,44].3.2. Whole brain DTI
At the threshold of pb0.01 (corrected), voxel-wise TBSS analysis
revealed lower FA only in bilateral parahippocampal WM in the MCI
group compared to HCs (Fig. 1) (cluster size, left: 252 mm3; right
176 mm3). Higher DR corresponded to lower FA in right parahippo-
campalWM inMCI patients compared to the HC group. Relative to the
CC group, participants with MCI showed signiﬁcantly lower FA in
bilateral parahippocampal WM with slightly larger clusters (left:
451 mm3; right 337 mm3). No region showed higher FA in MCI group
compared to HC or CC group. Moreover, voxel-based analysis of DTI
indices did not reveal any difference between CC and HC groups.p value Post-hoc comparison
0.200 NS
0.998 NS
0.128 NS
pb1×10−5 HCNMCI(pb1×10−5); CCNMCI (pb1×10−5)
pb1×10−5 HCNMCI(pb1×10−5); CCNMCI (pb1×10−5)
pb1×10−5 HCNMCI(pb1×10−5); CCNMCI (pb1×10−5)
pb1×10−5 HCNMCI(pb1×10−5); CCNMCI (pb1×10−5)
pb1×10−5 HCNMCI(pb1×10−5); CCNMCI (pb1×10−5)
pb1×10−5 HCNCC(pb0.05); HCNMCI (pb1×10−5); CCNMCI(pb0.001)
pb1×10−5 HCNCC(pb0.01); HCNMCI (pb1×10−5); CCNMCI(pb0.005)
each group. HC=healthy control; CC=cognitive complaint; MCI=mild cognitive
tot=Dementia Rating Scale-2 total scores (max 144); CVLT-IItot=California Verbal
Test-II short delay raw scores (max. 16); CVLT-II_LD=California Verbal Learning Test-II
y immediate recall raw scores (max. 75); WMS-III_LMD=Wechsler Memory Scale-III,
Fig. 1. Voxel-wise DTI comparison using tract-based spatial statistics analysis. The brain images showing underlying standard Montreal Neurological Institute (MNI) atlas MNI152
1-mm brain template and white matter skeleton derived from tract-based spatial statistics (TBSS) analysis (shown in green). Red color indicates tracts with reduced fractional
anisotropy (FA) in bilateral parahippocampal white matter in patients with MCI vs. controls; Blue color indicates region with increased radial diffusivity (DR) in right
parahippocampal white matter in MCI vs. controls. Only clusters surviving correction for multiple comparisons of voxel-wise whole brain analysis are shown on brain images
(pb0.01). Statistical maps were dilated from the TBSS skeleton for visualization purposes.
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We used the signiﬁcant bilateral parahippocampal clusters from
the FA contrast between MCI and HC as ROIs for subsequent analyses.
In addition to FA changes shown in TBSS, signiﬁcant differences
between MCI and HC were also found in DR of left parahippocampal
WM (pb0.05), and in all three diffusivity indices (MD, DR and DA) for
right parahippocampal WM (pb0.05), whereas MCI and CC only
differed in FA on these ROIs bilaterally (pb0.05). Consistent with
study hypotheses, the CC group demonstrated intermediate changes
of all diffusivity measures, with values falling between those of the
MCI and HC groups (Fig. 2A and B), except FA of left parahippocampal
ROI. Moreover, a signiﬁcant difference between the CC and HC groups
was found in MD of right parahippocampal ROI and a similar trend
was also found in DR and DA in the same region.
3.4. Relationship between DTI and memory/cognition
Cognitive scores showed modest but signiﬁcant positive correla-
tions with FA in the overall sample (see Table 2). Most correlations
with the MMSE, DRS-2, CVLT-II and WMS-III scores were found for
bilateral parahippocampalWM. Conversely, DR of the left andMD, DR,
DA of the right parahippocampalWMwere negatively correlated with
most of these neuropsychological measures. Speciﬁcally, lower FA of
the left parahippocampal WM and higher MD and DR of the right
parahippocampal WM were associated with lower neuropsycholog-
ical performance.
3.5. Additional analyses
We investigated the relationship between brain atrophymeasured
using FreeSurfer and DTI changes across groups. After controlling for
age, sex, education and ICV, signiﬁcantly smaller volume was found
only in bilateral hippocampi in MCI patients as compared to either HC
or CC groups (pb0.01). Consistent with previous report [2], CCs
showed intermediate hippocampal volume bilaterally, although the
difference between HC and CC was not statistically signiﬁcant. Nosigniﬁcant partial correlation was found between hippocampal
volume and DTI measures of parahippocampal WM in the overall
sample. We repeated the group comparison of DTI indices using ICV
normalized hippocampal volume as an additional covariate to further
test if DTI alone adds incremental information. Although the effect
size was slightly attenuated, all group differences in DTI indices in the
original analysis remained signiﬁcant indicating that the DTI indices
contribute independent information regarding stage-speciﬁc group
differences. Furthermore, in view of a recent report of the relationship
between education and WMmicrostructure in aging and AD [45], we
also repeated TBSS analyses using years of education as additional
covariate and found no signiﬁcant effect of education on ﬁnal results
in this sample.
4. Discussion
In this study, TBSS analysis of DTI measures demonstrated lower
FA and concordant higher DR in parahippocampal WM in the MCI
group reﬂecting regional abnormalities in WM microstructure and
integrity. These results are generally consistent with previous DTI
studies inMCI and AD [1,13,14,17–19]. The novel aspect of the present
report was the inclusion of a group of individuals with marked
cognitive complaints but psychometric performance within normal
limits. This CC group demonstrated intermediate DTI diffusivity values
in parahippocampal WM falling between the MCI and HC control
groups. This proﬁle of results suggests that DTI can contribute new
information related to WM changes at pre-MCI stages of probable AD.
Parahippocampal WM is comprised of multiple important ﬁber
systems, including the perforant pathway and ﬁbers projecting
from the amygdala to the parahippocampal region [13,14]. Recent
DTI results suggest that damage to the parahippocampal WM, in
addition to atrophic changes in the hippocampus and entorhinal
cortex, may contribute to memory dysfunction in MCI and AD
[13,14,17,19]. Various observations predict that axonal tract
degeneration in early AD would include parahippocampal WM
extending to, and continuing along, the posterior cingulum bundle
[14]. Emerging evidence indicates that disconnection of medial
Fig. 2. Group comparison using regions of interest (ROIs) analysis on DTI indices. Group comparison of DTI indices in (A) left parahippocampal white matter and (B) right
parahippocampal white matter. Age and sex adjusted means (± SE). (FA=fractional anisotropy; MD=mean diffusivity; DR=radial diffusivity; DA=axial diffusivity).
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course of AD and that demyelination may represent one contrib-
uting mechanism [11]. Higher DR with concomitant lower FA in theMCI group has been demonstrated in the parahippocampal WM,
suggesting that the pathology in this region includes some form of
myelin degradation [9,13]. In addition, we also found higher DA and
Table 2
Partial correlation coefﬁcients relating regional DTI indices and neuropsychological measures (controlled for age, gender and years of education).
Left parahippocampal WM Right parahippocampal WM
FA MD DR DA FA MD DR DA
MMSE 0.20* −0.06 −0.11 0.02 0.20* −0.11 −0.14 −0.05
DRStot 0.15 −0.08 −0.13 0.01 0.23* −0.27** −0.29** −0.21*
CVLT-IItot 0.27** −0.12 −0.19* −0.01 0.20* −0.22* −0.23* −0.20*
CVLT-II_SD 0.29** −0.16 −0.23* −0.04 0.10 −0.25* −0.25* −0.22*
CVLT-II_LD 0.25* −0.15 −0.21* −0.04 0.11 −0.23* −0.23* −0.21*
WMS-III_LM 0.24* −0.18 −0.24* −0.06 0.19* −0.20* −0.21* −0.17
WMS-III_LMD 0.21* −0.16 −0.22* −0.06 0.14 −0.19* −0.18 −0.19
Note: Symbol * indicates pb0.05; ** indicates pb0.01; WM=White Matter; FA=fractional anisotropy; MD=mean diffusivity; DR=radial diffusivity; DA=axial diffusivity;
MMSE=Mini-Mental State Examination (max 30); DRStot=Dementia Rating Scale-2 total scores (max 144); CVLT-IItot=California Verbal Learning Test-II total learning raw
scores (max 80); CVLT-II_SD=California Verbal Learning Test-II short delay raw scores (max. 16); CVLT-II_LD=California Verbal Learning Test-II long delay raw scores (max. 16);
WMS-III_LM=Wechsler Memory Scale-III, Logical Memory immediate recall raw scores (max. 75); WMS-III_LMD=Wechsler Memory Scale-III, Logical Memory delay recall raw
scores (max. 50).
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WM.
Nevertheless, the interpretation of differences in the measured
diffusion tensor is complexand shouldbeperformedwith care [6,14,15].
WhereasDTI is anestablishedmethod to illustrate diffusional properties
of white matter, the biological underpinning of tensor changes remains
incompletely understood [6,14,15]. It is widely assumed, for instance,
that phenomena such as demyelination and axonal loss may cause a
scenario inwhichFAreductions are drivenby increasedDRand constant
DA [8,14,46]. On the other hand, if changes in diffusion along the
directionof the semi-major axis of the tensor ellipsoid (measured asDA)
were proportional to those of the semi-minor axes (DR), then the FA,
which is a functionof this ratio,would remain relativelyunchanged [14].
It is conceivable, that contributions of other neurobiological processes
involved in white matter tract degeneration such as destruction of
neuroﬁbrils and glial alterations can give rise to diffusion tensor
behaviors that are not fully captured by FA changes [14].
In this study, we did not observe a difference in FA between the CC
and HC groups; however, there was a signiﬁcantly higher MD of right
parahippocampal WM in the CC group relative to controls, while
regional DR and DA showed similar trends. Moreover, the DTI indices
were found in association with declarative memory performance. It
has been reported that high MD values in the hippocampal formation
of healthy elderly individuals predict memory decline [20]. Rogalski
and colleagues [19] also found that MCI demonstrated a signiﬁcant
increase in MD, but no difference in FA, both in the parahippocampal
WM region and in ﬁbers modeled to pass through the parahippo-
campal region.
Consistent with our previous VBM reports [2,4,39], the present
results demonstrate that compared to controls, MCI patients have
volume loss in the hippocampus. Although the relation between DTI
measures and more classical imaging indices of pathology, including
brain volume, is not fully understood, a recent study in AD suggests
that alteration of DTI measures, including effects in the parahippo-
campal WM, is independent of gray matter degeneration as measured
by hippocampal volume [13]. Our results showing diffusion alteration
in parahippocampal WM in prodromal AD after controlling for
hippocampal volume are in accord with this ﬁnding. These results
suggest a pattern of general emerging parenchymal loss and
degradation (smaller volume and higher MD) in individuals with CC
compared to healthy older people. However, the microstructural
organization of remaining ﬁbers, as determined by measures of
anisotropic diffusion, is not signiﬁcantly different from that of
controls. Thus, diffusivity measures might be more sensitive than FA
predicting earliest changes of WM microstructure in prodromal AD
[19]. One can also speculate that there may be greater changes in the
absolute dimensions of the diffusion ellipsoid rather than in its shape
at very early stage of AD [14]. This prediction would translate to
concordant and more sensitive results for DA, DR and MD when
compared with FA [14].The present study has several limitations. First, this cohort is
highly educated and therefore may not be broadly representative of
patients with prodromal AD. It has been hypothesized that WM
microstructure may contribute to brain reserve capacity in humans
[47]. Individuals with higher education and cognitive reserve might
be more sensitive to subtle decline in cognitive function and therefore
may present themselves for research participation with higher
frequency than samples with lower education. Second, several recent
reports indicated an inﬂuence of AD risk factors such as APOE epsilon
4 allele status and family history of dementia onWM integrity [11,21].
We did not ﬁnd statistically signiﬁcant effects of these variables but it
should be noted that the present study did not have sufﬁcient power
to detect relatively small effects of these variables or interactions
among these factors. Future DTI studies of WM integrity in pre- and
prodromal AD samples should continue to address genetic and other
AD risk factors.
In conclusion, our results, together with other recent ﬁndings,
suggest that DTI may be able to serve as an additional stage-related
biomarker that can contribute information above and beyond
established medial temporal atrophy and cognitive measures.
Finally, the present study conﬁrmed and extended previous VBM
ﬁndings that cognitive complaints in older adults may indicate
underlying neurodegenerative changes even when unaccompanied
by deﬁcits on formal testing [2,3]. The CC group may represent a pre-
MCI stage and may provide an earlier therapeutic opportunity
than mild cognitive impairment [3]. However, the rate to which
older adults with cognitive complaints progress to AD or other
types of dementia has been somewhat controversial and may relate
to ascertainment methodology and sample speciﬁc characteristics.
We will continue to follow this cohort to examine longitudinal
changes. The ﬁeld is shifting toward a biomarker based assessment
of risk in detection of AD including amyloid PET, CSF analytes
and structural MRI [48]. The present study contributes to the body of
work suggesting a potential role for DTI yet additional research is
needed to demonstrate the sensitivity and speciﬁcity of early WM
changes.
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